Skip to content

Evaluation and comparison of the effect of thromboelastography and Anti-Xa activity assay in the treatment of gynecological VTE

Evaluation and comparison of the effect of thromboelastography and Anti-Xa activity assay in the treatment of gynecological VTE

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053224
Enrollment
Unknown
Registered
2021-11-16
Start date
2021-01-01
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thrombosis

Interventions

case series:Nil

Sponsors

Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 75 years. 2.Patients underwent surgery for gynecological disease. 3.VTE was confirmed by the lower extremity vascular compressed ultrasound and/or CTPA in those patients with abnormal D-dimer's result(great than 3mg/L or significantly higher than before) after gynecological surgery. 4.Patients or family members who can understand the study protocol and are willing to participate in the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who are undergoing anticoagulation with a history of VTE. 2.Patients who have severe disfunction in liver and/or kidney. 3.Patients who have a history of hematological disease. 4.Blood platlet count less than 50 x 10^9/L. 5.Patients who are unfit to LMWH such as with a history of HIT or other reason.

Design outcomes

Primary

MeasureTime frame
TEG parameters;

Countries

China

Contacts

Public ContactWeimin Tao

Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University

kyada@sina.com+86 13818362930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026